Cariprazine Use in Early Psychosis: Three Case Reports

Objective: Cariprazine is a new atypical antipsychotic approved for the acute and maintenance treatment of schizophrenia (1, 2) and for the treatment of manic or mixed episodes associated with bipolar I disorder (1). Recently, cariprazine also got extended FDA-approval for the treatment of depressiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Coentre, Ricardo, Saraiva, Rodrigo, Sereijo, Carolina, Levy, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716595/
https://www.ncbi.nlm.nih.gov/pubmed/34975583
http://dx.doi.org/10.3389/fpsyt.2021.788281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8716595/
https://www.ncbi.nlm.nih.gov/pubmed/34975583
http://dx.doi.org/10.3389/fpsyt.2021.788281

Ejemplares similares